Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Verrica Pharmaceuticals Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Fees to be Paid | Equity | Common stock, par value $0.0001 per share |
— | (1) | (2) | (2) | — | — | ||||||||||||||||
| Equity | Preferred stock, par value $0.0001 per share |
— | (1) | (2) | (2) | — | — | |||||||||||||||||
| Debt | Debt Securities | — | (1) | (2) | (2) | — | — | |||||||||||||||||
| Other | Warrants | — | (1) | (2) | (2) | — | — | |||||||||||||||||
| Unallocated (Universal) shelf |
— | Rule 457 (o) | (1) | (2) | $150,000,000 | 0.00015310 | $22,965.00(2) | |||||||||||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||||||||||
| Carryforward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
Equity | Common stock, par value $0.0001 per share |
— | — | — | — | ||||||||||||||||||
| Equity | Preferred stock, par value $0.0001 per share |
— | — | — | — | |||||||||||||||||||
| Debt | Debt Securities | — | — | — | — | |||||||||||||||||||
| Other | Warrants | — | — | — | — | |||||||||||||||||||
| Unallocated (Universal) Shelf |
Unallocated (Universal) Shelf |
Rule 415(a)(6) | (1) | $18,115,967.08 (2)(3) | — | S-3 | 333-268229 | December 19, 2022 | $2,773.55 (3) | |||||||||||||||
| Total Offering Amounts | $150,000,000(1)(3) | $22,965.00 | ||||||||||||||||||||||
| Total Fees Previously Paid | $2,773.55 (3) | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $ 20,191.45 | |||||||||||||||||||||||
| (1) | There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, and such indeterminate number of warrants to purchase common stock, preferred stock or debt securities as shall have an aggregate initial offering price not to exceed $150,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $150,000,000, less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The securities registered also include such indeterminate amounts and numbers of common stock, preferred stock, and debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
| (2) | The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Item 16(b) of Form S-3 under the Securities Act. |
| (3) | Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include $18,115,967.08 of unsold securities (the “Unsold Securities”) previously registered and offered by the registrant pursuant to the Registration Statement on Form S-3 (File No. 333-268229) (the “Prior Registration Statement”), which was declared effective on December 19, 2022. In connection with the filing of the Prior Registration Statement, the registrant paid a filing fee of $19,470.00 with respect to an aggregate of $150,000,000 of securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). Of this amount, $2,773.55 is associated with the Unsold Securities. Pursuant to Rule 457(p), the filing fee associated with the offering of the Unsold Securities is hereby carried forward to be applied to the Unsold Securities registered hereunder. To the extent that, after the filing date hereof and prior to the effectiveness of this Registration Statement, the registrant sells any Unsold Securities pursuant to the Prior Registration Statement, the registrant will identify in a pre-effective amendment to this Registration Statement the updated amount of Unsold Securities from the Prior Registration Statement to be included in this Registration Statement pursuant to Rule 415(a)(6). The offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement. |